Topic: Biological Agents
Presented by: Office of Grants and Training National Domestic Preparedness Consortium
Key focus: Understanding biological agents and their impact in planning responses to WMD events.
Understand the RAIN concept as it applies to biological agents:
Recognize clinical characteristics of biological agents.
Avoid hazards and prevent illness caused by biological agents.
Isolate biological hazards and patients with contagious diseases.
Notify appropriate resources when responding to a WMD event.
Describe different biological agents.
Identify general signs and symptoms of exposure to biological agents.
Discuss physical characteristics of biological agents.
Review advantages and disadvantages of using biological agents for terrorism.
Dissemination Types: Aerosol, solid, liquid.
Routes of Entry: Inhalation, contact, ingestion, injection.
General Signs/Symptoms of Exposure: May include flu-like symptoms, fever, chills, nausea.
Mortality Rates: Varied based on agent and promptness of treatment.
Basic Treatment Options: Antibiotics, supportive care depending on the agent.
**Washington D.C. Schools Suspicious Powder Incident (
Date: May 6, 2011.
Impact: Response to envelopes with suspicious powder referencing FBI and al-Qaeda.
Security in Biodefense Labs: Concerns regarding lack of global security rules for labs studying lethal pathogens.
Protection of African Pathogens: Urging for security to prevent misuse in biological attacks.
Cost of Producing Mass Casualties Per Square Kilometer:
Conventional: $2,000
Nuclear: $800
Chemical: $600
Biological: $1
Category A: High-priority agents like Anthrax, Plague, Smallpox.
Category B: Lower threat, includes agents like Ricin, Q fever.
Category C: Emerging pathogens like Nipah virus and Yellow fever.
Anthrax (Bacillus anthracis):
Routes of Entry: Inhalation, contact, ingestion.
Mortality: Can be fatal without treatment, early treatment is crucial.
Treatment: Ciprofloxacin, Tetracyclines, Penicillins.
Plague (Yersinia pestis):
Routes of Entry: Aerosol, ingestion, injection.
Symptoms: High fever, chills, coughing up blood.
Treatment: Early antibiotics needed within 24 hours of symptoms.
Tularemia (Francisella tularensis):
Routes of Entry: Inhalation, contact, injection.
Symptoms: Sudden fever, fatigue, joint pain.
Mortality: Relatively low but requires treatment.
Smallpox (Variola virus):
Routes of Entry: Inhalation.
Symptoms: Fever, malaise, vomiting.
Mortality: Up to 30% of cases; no proven treatment available.
Ricin (Ricinus communis):
Routes of Entry: Inhalation, ingestion, injection.
Symptoms: Weakness, dizziness, respiratory failure.
Treatment: Supportive care, no antidote.
Abrin: Similar to ricin but more toxic; usage in experiments by individuals has been noted.
First Bioterrorism Example in North America:
Smallpox used against Native Americans in 1763 and British tactics reported in 1777 highlighted risks of biological warfare.
Available, hard to detect, covert use, easily spread, psychological impact.
Can have delayed effects, hazardous production, environmental factors can limit effectiveness.
Local Sources of Threats: Agriculture, laboratories, food industries, waste disposal, etc.
Importance of Self-Protection: Proper sanitation, personal protective equipment, and decontamination measures.
Rapid recognition of potential bioterrorism events is crucial.
Requires continuous training and community awareness to respond effectively to biological threats.